# Astral VAPS AutoEPAP Clinical Trial

> **NCT02683772** · PHASE3 · COMPLETED · sponsor: **ResMed** · enrollment: 42 (actual)

## Conditions studied

- Upper Airway Obstruction
- Respiratory Insufficiency
- Respiratory Failure

## Interventions

- **DEVICE:** Astral

## Key facts

- **NCT ID:** NCT02683772
- **Lead sponsor:** ResMed
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-04-15
- **Primary completion:** 2017-03-01
- **Final completion:** 2017-07-06
- **Target enrollment:** 42 (ACTUAL)
- **Last updated:** 2019-07-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02683772

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02683772, "Astral VAPS AutoEPAP Clinical Trial". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02683772. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*